|
[1]
|
Nguyen, L.H., Goel, A. and Chung, D.C. (2020) Pathways of Colorectal Carcinogenesis. Gastroenterology, 158, 291-302. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Song, M., Emilsson, L., Bozorg, S.R., et al. (2020) Risk of Colorectal Cancer Incidence and Mortality after Polypectomy: A Swedish Record-Linkage Study. The Lancet Gastroenterology & Hepatology, 5, 537-547. [Google Scholar] [CrossRef]
|
|
[3]
|
Baron, J.A., Cole, B.F., Sandler, R.S., et al. (2003) A Ran-domized Trial of Aspirin to Prevent Colorectal Adenomas. New England Journal of Medicine, 348, 891-899. [Google Scholar] [CrossRef]
|
|
[4]
|
Zhang, Y., Chen, L. and Chen, H. (2021) A Meta-Analysis of the Correlation between Non-Steroidal Anti-Inflammatory Drugs and Recurrent Colorectal Adenomatous Polyps. American Journal of Translational Research, 13, 2432. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Chudy-Onwugaje, K., Huang, W.Y., Su, L.J., et al. (2021) Aspirin, Ibuprofen, and Reduced Risk of Advanced Colorectal Adenoma Incidence and Recurrence and Colorectal Cancer in the PLCO Cancer Screening Trial. Cancer, 127, 3145-3155. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Arefi, H., Naderi, N., Shemirani, A.B.I., et al. (2020) Design, Synthesis, and Biological Evaluation of New 1,4-Diarylazetidin-2-One Derivatives (β-Lactams) as Selective Cyclooxygenase-2 In-hibitors. Archiv Der Pharmazie, 353, Article ID: 1900293. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Veettil, S.K., Nathisuwan, S., Ching, S.M., et al. (2019) Efficacy and Safety of Celecoxib on the Incidence of Recurrent Colo-rectal Adenomas: A Systematic Review and Meta-Analysis. Cancer Management and Research, 11, 561. [Google Scholar] [CrossRef]
|
|
[8]
|
Arber, N., Spicak, J., Rácz, I., et al. (2011) Five-Year Analysis of the Prevention of Colorectal Sporadic Adenomatous Polyps Trial. Official Journal of the American College of Gastroen-terology, 106, 1135-1146. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Chan, K.K.W., Oza, A.M. and Siu, L.L. (2003) The Statins as Anticancer Agents. Clinical Cancer Research, 9, 10-19.
|
|
[10]
|
Gong, L., Xiao, Y., Xia, F., et al. (2019) The Mevalonate Coordinates Energy Input and Cell Proliferation. Cell Death & Disease, 10, Article No. 327. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Li, L., Cui, N., Hao, T., et al. (2021) Statins Use and the Progno-sis of Colorectal Cancer: A Meta-Analysis. Clinics and Research in Hepatology and Gastroenterology, 45, Article ID: 101588. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Siddiqui, A., Pandove, S., Mahgoub, A., et al. (2008) The Long-Term Use of Statins Is Associated with a Decreased Incidence of Advanced Adenomatous Colon Polyps: 1388. Official Journal of the American College of Gastroenterology, 103, S544. [Google Scholar] [CrossRef]
|
|
[13]
|
Chen, Y.A., Lin, Y.J., Lin, C.L., et al. (2018) Simvas-tatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients with Hyperlipidemia. Frontiers in Pharmacology, 9, Article No. 225. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Siddiqui, A.A., Nazario, H., Mahgoub, A., et al. (2009) The Long-Term Use of Statins Is Associated with a Decreased Incidence of Adenomatous Colon Polyps. Digestion, 79, 17-22. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Renelus, B.D., Dixit, D., Nguyen, P.T., et al. (2021) Short-Term Aspirin and Statin Chemoprophylaxis Did Not Reduce the Risk of Developing Advanced Adenomatous Polyps in Black Patients. BMC Gastroenterology, 21, Article No. 379. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Collins, K.K. (2014) The Diabetes-Cancer Link. Diabetes Spectrum, 27, 276-280. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Zhou, G., Myers, R., Li, Y., et al. (2001) Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action. The Journal of Clinical Investigation, 108, 1167-1174. [Google Scholar] [CrossRef]
|
|
[18]
|
Hosono, K., Endo, H., Takahashi, H., et al. (2010) Metformin Suppresses Azoxymethane-Induced Colorectal Aberrant Crypt Foci by Activating AMP-Activated Protein Kinase. Molecular Car-cinogenesis, 49, 662-671. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Singh, S., Singh, H., Singh, P.P., et al. (2013) Antidiabetic Medications and the Risk of Colorectal Cancer in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis. Cancer Epi-demiology and Prevention Biomarkers, 22, 2258-2268. [Google Scholar] [CrossRef]
|
|
[20]
|
Ng, C.A., Jiang, A.A., Toh, E.M.S., et al. (2020) Metformin and Colorectal Cancer: A Systematic Review, Meta-Analysis and Meta-Regression. International Journal of Colorectal Disease, 35, 1501-1512. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Mansourian, M., Karimi, R. and Vaseghi, G. (2018) Different Effects of Metformin and Insulin on Primary and Secondary Chemoprevention of Colorectal Adenoma in Diabetes Type 2: Traditional and Bayesian Meta-Analysis. EXCLI Journal, 17, 45.
|
|
[22]
|
Soltani, G., Poursheikhani, A., Yassi, M., et al. (2019) Obesity, Diabetes and the Risk of Colorectal Adenoma and Cancer. BMC Endocrine Disorders, 19, Article No. 113. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Gao, Y., Katki, H., Graubard, B., et al. (2012) Serum IGF1, IGF2 and IGFBP3 and Risk of Advanced Colorectal Adenoma. International Journal of Cancer, 131, E105-E113. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Higurashi, T., Hosono, K., Takahashi, H., et al. (2016) Metformin for Chemoprevention of Metachronous Colorectal Adenoma or Polyps in Post-Polypectomy Patients without Diabetes: A Multicentre Double-Blind, Placebo-Controlled, Randomised Phase 3 Trial. The Lancet Oncology, 17, 475-483. [Google Scholar] [CrossRef]
|
|
[25]
|
Khosravi, M. (2021) Ursodeoxycholic Acid in Patients with Treatment-Resistant Schizophrenia Suffering from Coronavirus Disease 2019: A Hypothesis Letter. Frontiers in Psychi-atry, 12, Article ID: 657316. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Alberts, D.S., Martínez, M.E., Hess, L.M., et al. (2005) Phase III Trial of Ursodeoxycholic Acid to Prevent Colorectal Adenoma Recurrence. Journal of the National Cancer Institute, 97, 846-853. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Pearson, T., Caporaso, J.G., Yellowhair, M., et al. (2019) Effects of Ursodeoxycholic Acid on the Gut Microbiome and Colorectal Adenoma Development. Cancer Medicine, 8, 617-628. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Wien, T.N., Pike, E., Wisløff, T., et al. (2012) Cancer Risk with Folic Acid Supplements: A Systematic Review and Meta-Analysis. BMJ Open, 2, e000653. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Troen, A.M., Mitchell, B., Sorensen, B., et al. (2006) Un-metabolized Folic Acid in Plasma Is Associated with Reduced Natural Killer Cell Cytotoxicity among Postmenopausal Women. The Journal of Nutrition, 136, 189-194. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Kim, D.H., Smith-Warner, S.A., Spiegelman, D., et al. (2010) Pooled Analyses of 13 Prospective Cohort Studies on Folate Intake and Colon Cancer. Cancer Causes & Control, 21, 1919-1930. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Jaszewski, R., Misra, S., Tobi, M., et al. (2008) Folic Acid Supplementation Inhibits Recurrence of Colorectal Adenomas: A Randomized Chemoprevention Trial. World Journal of Gastroenterology, 14, 4492-4498. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Meenan, J., O’Hallinan, E., Scott, J. and Weir, D.G. (1997) Epithelial Cell Folate Depletion Occurs in Neoplastic but Not Adjacent Normal Colon Mucosa. Gastroenterology, 112, 1163-1168. [Google Scholar] [CrossRef]
|
|
[33]
|
Chae, Y.K. and Yun, J.H. (2007) Folic Acid and Prevention of Colorectal Adenomas. JAMA, 298, 1397. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Bolland, M.J., Grey, A., Gamble, G.D., et al. (2011) Calcium and Vitamin D Supplements and Health Outcomes: A Reanalysis of the Women’s Health Initiative (WHI) Limited-Access Data Set. The American Journal of Clinical Nutrition, 94, 1144-1149. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Bonithon-Kopp, C., Kronborg, O., Giacosa, A., et al. (2000) Calcium and Fibre Supplementation in Prevention of Colorectal Adenoma Recurrence: A Randomised Intervention Trial. The Lancet, 356, 1300-1306. [Google Scholar] [CrossRef]
|
|
[36]
|
Wallace, K., Baron, J.A., Cole, B.F., et al. (2004) Effect of Calcium Supplementation on the Risk of Large Bowel Polyps. Journal of the National Cancer Institute, 96, 921-925. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Rifkin, S.B., Giardiello, F.M., Zhu, X., et al. (2020) Yogurt Consumption and Colorectal Polyps. British Journal of Nutrition, 124, 80-91. [Google Scholar] [CrossRef]
|
|
[38]
|
Emami, M.H., Salehi, M., HassanzadehKeshteli, A., et al. (2021) Calcium and Dairy Products in the Chemoprevention of Colorectal Adenomas: A Systematic Review and Meta-Analysis. Critical Reviews in Food Science and Nutrition, 6, 1-25. [Google Scholar] [CrossRef] [PubMed]
|